Trauma Devices | Asia Pacific | 2017 | Market Analysis
The Asia Pacific trauma device market will grow moderately through 2025 as rising procedure volumes—due to favorable demographics and increased accessibility to health care in some of the countries—as well as growing use of premium-priced products offset market limiters, such as a challenging reimbursement environment, nationalist policies in China and India, and pricing pressures.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region across a 10-year period.
The aging population and rising middle class in China and India will largely dictate the growth of the overall market.
As the largest market in the Asia Pacific region, to what extent will procedure volumes grow within the Chinese market for trauma devices?
How will the Indian market grow in comparison to China and the rest of the Asia Pacific region?
How will health care reforms affect the growth potential of these markets?
Strong competition between MNCs and domestic players has placed downward pressure on device prices, leading to price declines in the Asia Pacific trauma device market.
What impact will the increasing presence of domestic manufacturers have on Asia Pacific trauma device ASPs?
What other strategies are companies using to remain competitive in the face of strong pricing pressures?
The Asia Pacific trauma device market is particularly fragmented, with a varied mix between large international companies and smaller domestic competitors.
What are the key competitive strategies that foreign MNCs and local companies must be mindful of?
How will protectionist trade policies affect growth through 2025?
How will purchasing priorities in this region evolve going forward?
